RAD News and Press, Rite Aid Corporation From 05/17/23

2023-05-17 21:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-05-12 13:41:59 ET Summary CVS is undervalued and generates impressive cash flow, but it faces competition, regulatory challenges, and low operating margins, resulting in mediocre returns on capital. Before investing, I believe an investor should study the complex operations b...

Trivehexin radiopharmaceuticals being developed for imaging and treatment of cancers expressing αvβ6-integrin Pancreatic ductal adenocarcinoma is primary indication due to high unmet need Potential follow-on indications include non-small cell lung cancer, head and ...

2023-05-08 05:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

On the Hunt to End Seasonal Allergy Suffering, New Data Uncovers Insights on Remedies It’s no secret seasonal allergies are here. From runny noses and itchy eyes to tissues carried in all pockets and bags, spring has sprung and mother nature has brought the dreaded sneeze with he...

2023-04-20 11:20:02 ET Rite Aid Corporation (RAD) Q4 2023 Earnings Conference Call April 20, 2023, 08:30 AM ET Company Participants Byron Purcell - Vice President, Investor Relations and Treasurer Elizabeth "Busy" Burr - Interim Chief Executive Officer Matt Schro...

2023-04-20 08:33:06 ET The following slide deck was published by Rite Aid Corporation in conjunction with their 2023 Q4 earnings call. For further details see: Rite Aid Corporation 2023 Q4 - Results - Earnings Call Presentation

2023-04-20 07:03:44 ET Rite Aid press release ( NYSE: RAD ): Q4 GAAP EPS of -$4.39 misses by $3.22 . Revenue of $6.1B (+0.5% Y/Y) beats by $400M . Adjusted EBITDA of $128.6 million, Compared to the Prior Year Adjusted EBITDA of $106.1 million. Outlook: ...

Fourth Quarter Highlights: Revenues of $6.1 billion, Comparable to Prior Year Retail Comparable Same Store Prescriptions Increased 5.2 Percent – Comparable Same Store Prescriptions, Excluding COVID Impacts, Increased 9.7 Percent Net Loss per Share of $4.39, Comp...

2023-04-19 15:40:05 ET U.S. Supreme Court Justice Samuel Alito on Wednesday extended a temporary pause on lower court rulings that would have imposed restrictions on the abortion pill mifepristone to Friday at 11:59 PM EST. The decision gives more time for justices to consider th...